Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for Heart Rate Control In Septic Shock
NCT04031573Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2021
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in septic shock, sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2021; status: completed.
02
Drugs
ivabradine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04031573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04031573.